Skip to content
Pharma Observatory a Scientist.com platform
  • Supplier site
  • Group of sites (click to zoom)

Scientist.com supplier network (site locations)

Research supplier

Self Care Catalysts

Self Care Catalysts is listed as a small business research supplier in the Scientist.com network, with 1 site in 1 country.

View Self Care Catalysts on Scientist.com

Sign in to Scientist.com to open this supplier in your organization's marketplace.

Email me this page as a PDF

Search companies, drugs, suppliers and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Sites 1
Countries 1

Services

What this research supplier says it provides, as listed in the Scientist.com network.

Type of company: Small business

Clinical Trials

  • ePRO - Electronic Patient-reported Outcome Patient reported outcome collected by electronic methods.
  • Prospective Explorative Studies Conduct a prospective exploratory study to assess the safety and efficacy of a test drug during clinical trials.

HEOR

  • Clinical Outcome Assessments (Non-Patient Reported) Measure a patient's symptoms, mental state and level of disease condition-related impact on daily life.
  • Clinical Outcomes Measures patient's symptoms, mental, or physical effects of a disease or condition on how the patient functions, recorded by practitioner, provider, or instrument (not by patient).
  • Decision Analytic Modeling Assess effects, costs and economic outcomes of treatment. These include cost-effectiveness models and budget impact models.
  • Health Economics and Outcomes Research (HEOR) Evaluate data collected during drug development to maximize the value of a therapeutic product.
  • HEOR Adherence Studies Strategy or study that assess extent to which patients or subjects follow recommendations for prescribed intervention; may include compliance assessment, as well as reasons related to actual or potential non-adherence.
  • Patient Reported Outcomes (PRO) Assessment of health outcomes directly reported by the patient who experienced it, without interpretation of the patient's response by a clinician.
Show all 9 in HEOR 3 more
  • Patient Treatment Patterns Assessment of treatment processes and patterns within clinical practice.
  • Resource Utilization Descriptive and/or analytical review of a treatment that investigate the marketing, distribution, prescription, and use of drugs in populations. Endpoints to be assessed are the medical, social, and economic outcomes.
  • Therapy Switch Insight into the reasoning of patients switching treatments and the outcomes of the switch.

Market Access

  • Market Access Materials Find general strategies and methods used to market a pharmaceutical product or device.
  • Market Research & Business Intelligence Run market feasibility studies, establish customer needs, improve product performance and analyze competition.
  • Marketing and Commercialization Identify, promote and prove the value of a particular drug to key stakeholders.
  • Value Based Agreements or Outcomes-Based Contracts Collaborate with payer or provider to develop a reimbursement plan outside of the traditional fixed cost-per-unit that ties reimbursement or price to actual health outcomes.
Show all 34 services 22 more

Medical/Commercial

  • Health & Pharmacoeconomics Identify, measure and compare the cost-benefit ratio of products and services.
  • Life Cycle Assessment (LCA) Analyze the lifecycles of the products and services with regard to their environmental impacts.

Old Category HEOR, RWE, Market Access

  • Non-Interventional Studies Examine different aspects of drug usage, including efficacy and safety, under real-life conditions.
  • Patient-Reported Outcome Studies Get self-reported information regarding the personal health status of an individual.

Real World Evidence & Data

  • Clinical Data Registry A study or collection of data regarding the health of patients and the care they receive over different time periods.
  • Exploratory Study Explore study design, outcomes, data-collection method, and selection of population for a topic that needs more research information.
  • Non-Comparative Study Assess an intervention using a single arm study design (without a control or comparator group).
  • Patient Reported Outcomes (PRO) Databases Database or collection of data related to health outcomes directly reported by the patient who experienced it, without interpretation of the patient's response by a clinician or anyone else.
  • Pragmatic Clinical Trial Randomized trial comparing two or more treatments in a real world setting. The trial possesses minimal exclusion criteria and closely follows the procedures of the clinical practice in order to mirror clinical care...
  • Real World Evidence (RWE) Studies Studies (prospective or retrospective) utilizing data obtained from "real world settings" , and is outside the tight controls of a clinical trial design.
Show all 12 in Real World Evidence & Data 6 more
  • Real-World Data Acquire real-world data from patients' electronic medical records including clinical information generated during the course of healthcare.
  • Real-World Evidence Acquire clinical data from patients' medical records to analyze trends and the frequency of occurrence of different medical conditions.
  • Registries - Disease Database containing, through utilizing observational research methods, standardized data about patients who have the same disease.
  • Registries - Patient Database containing, through utilizing observational research methods, standardized data about patients who have the same condition, disease, or exposure and is used to evaluate an outcome
  • Retrospective Exploratory Studies Retrospective exploratory studies
  • RWE/RWD Observational Research Research method for documenting clinical, economic, and or humanistic outcomes of actual medical practice absent the constraints of a more formal experimental design. See also Pragmatic Clinical Trials.

Regulatory Affairs

  • Life Cycle Management Plan and strategy of the data collection and information throughout the different phases of product development (portfolio assessment, pre-clinical trials, clinical trials, pre-authorization, post-authorization, and RWE)
  • Risk Benefit Assessment Determine ratio of treatment risk to the potential benefits.

Other services

  • Observational Research Gain valuable insights into the association between a drug treatment and its outcomes such as long-term effectiveness and safety.

Source: Scientist.com supplier network

Where it operates

Sites by country, with the cities in each.

  • Canada Toronto 1 site

Source: Scientist.com supplier network (site locations)

Get the Self Care Catalysts report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Sources: Scientist.com supplier network.

Work with Self Care Catalysts on Scientist.com

For prices, more details, or to contact Self Care Catalysts, visit Scientist.com.

Sign in to Scientist.com to open this supplier in your organization's marketplace.